INOVIQ Ltd (ASX:IIQ) Insider Philip (Phil) Powell Buys 50,000 Shares

INOVIQ Ltd (ASX:IIQ) insider Philip (Phil) Powell purchased 50,000 shares of INOVIQ stock in a transaction on Monday, March 10th. The stock was bought at an average price of A$0.35 ($0.22) per share, for a total transaction of A$17,500.00 ($11,075.95).

INOVIQ Stock Performance

The company has a debt-to-equity ratio of 2.02, a current ratio of 7.07 and a quick ratio of 9.52. The stock has a market cap of $47.40 million, a price-to-earnings ratio of -6.02 and a beta of 2.04.

About INOVIQ

INOVIQ Ltd engages in the research, development, and commercialization of diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. The company offers hTERT test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET for capturing and isolating exosomes from liquid biopsy sample.